These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12435378)

  • 1. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex.
    Ballard CG; Court JA; Piggott M; Johnson M; O'Brien J; McKeith I; Holmes C; Lantos P; Jaros E; Perry R; Perry E
    Conscious Cogn; 2002 Sep; 11(3):461-74. PubMed ID: 12435378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.
    Pimlott SL; Piggott M; Ballard C; McKeith I; Perry R; Kometa S; Owens J; Wyper D; Perry E
    Neurobiol Dis; 2006 Jan; 21(1):50-6. PubMed ID: 16023355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.
    Court JA; Ballard CG; Piggott MA; Johnson M; O'Brien JT; Holmes C; Cairns N; Lantos P; Perry RH; Jaros E; Perry EK
    Pharmacol Biochem Behav; 2001 Dec; 70(4):571-9. PubMed ID: 11796155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
    Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
    Acta Neurol Scand Suppl; 2000; 176():34-41. PubMed ID: 11261803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
    Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
    Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
    Teaktong T; Piggott MA; Mckeith IG; Perry RH; Ballard CG; Perry EK
    Behav Brain Res; 2005 Jun; 161(2):299-305. PubMed ID: 15922057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.
    Rei RT; Sabbagh MN; Corey-Bloom J; Tiraboschi P; Thal LJ
    Neurobiol Aging; 2000; 21(5):741-6. PubMed ID: 11016544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ; Meinerz NM; Drago J; Collins AC
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies.
    Sabbagh MN; Reid RT; Hansen LA; Alford M; Thal LJ
    J Neural Transm (Vienna); 2001; 108(10):1149-57. PubMed ID: 11725817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
    Bohr IJ; Ray MA; McIntosh JM; Chalon S; Guilloteau D; McKeith IG; Perry RH; Clementi F; Perry EK; Court JA; Piggott MA
    Exp Neurol; 2005 Feb; 191(2):292-300. PubMed ID: 15649484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor abnormalities in the cerebellar cortex in autism.
    Lee M; Martin-Ruiz C; Graham A; Court J; Jaros E; Perry R; Iversen P; Bauman M; Perry E
    Brain; 2002 Jul; 125(Pt 7):1483-95. PubMed ID: 12076999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Medial Temporal Lobe Atrophy and Cognitive Impairment in Patients With Dementia With Lewy Bodies.
    Tagawa R; Hashimoto H; Nakanishi A; Kawarada Y; Muramatsu T; Matsuda Y; Kataoka K; Shimada A; Uchida K; Yoshida A; Higashiyama S; Kawabe J; Kai T; Shiomi S; Mori H; Inoue K
    J Geriatr Psychiatry Neurol; 2015 Dec; 28(4):249-54. PubMed ID: 26071442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
    Duda JE
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.
    Ballard C; Piggott M; Johnson M; Cairns N; Perry R; McKeith I; Jaros E; O'Brien J; Holmes C; Perry E
    Ann Neurol; 2000 Dec; 48(6):868-76. PubMed ID: 11117543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.